Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-14 | IDXX | Schreck Michael | EVP | F - Tax | $629.35 | -876 | 3,089 | -22% | -$551.3K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Schreck Michael | EVP | M - OptEx | $0.00 | +1,959 | 2,123 | +1,197% | $0 |
| DM | 2026-02-17 | 2026-02-12 | IDXX | Schreck Michael | EVP | A - Grant | $0.00 | +7,501 | 1,620 | New | $0 |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Schreck Michael | EVP | M - OptEx | $0.00 | -1,959 | 1,101 | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | F | D | 876 | $629.35 | 3,088.71 | D | — | — | (F2) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. |
| 2 | Common | Common Stock | 2026-02-14 | M | A | 1,005 | $0.00 | 3,964.71 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-14 | M | A | 367 | $0.00 | 2,959.71 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-14 | M | A | 301 | $0.00 | 2,592.71 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-14 | M | A | 169 | $0.00 | 2,291.71 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-14 | M | A | 117 | $0.00 | 2,122.71 | D | — | — | (F1) Includes a total of 49.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025. |
| 7 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-12 | A | A | 4,625 | $0.00 | 4,625 | D | $617.20 · — to 2036-02-11 | 4,625 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. |
| 8 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-12 | A | A | 162 | $0.00 | 162 | D | $617.20 · — to 2036-02-11 | 162 Common Stock | (F4) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 1,094 | $0.00 | 1,094 | D | — · — to — | 1,094 Common Stock | (F5) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027. |
| 10 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 1,620 | $0.00 | 1,620 | D | — · — to — | 1,620 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027. |
| 11 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 117 | $0.00 | 0 | D | — · — to — | 117 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments beginning February 14, 2023. |
| 12 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 169 | $0.00 | 169 | D | — · — to — | 169 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2024. |
| 13 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 1,005 | $0.00 | 0 | D | — · — to — | 1,005 Common Stock | (F11) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2026. |
| 14 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 301 | $0.00 | 602 | D | — · — to — | 301 Common Stock | (F9) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning February 14, 2025. |
| 15 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 367 | $0.00 | 1,101 | D | — · — to — | 367 Common Stock | (F10) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026. |